Article information
Full text is only aviable in PDF
References
[1.]
A.J.M. Ferreri, E. Campo, J.F. Seymour, R. Willemze, F. Ilariucci, A. Ambrosetti, et al.
Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the “cutaneous variant”.
Br J Haematol, 127 (2004), pp. 173-183
[2.]
X. Beristain, B. Azzarelli.
The neurological masquerade of intravascular lymphomatosis.
Arch Neurol, 59 (2002), pp. 439-443
[3.]
M.D. Kraus, D. Jones, N.L. Bartlett.
Intravascular lymphoma associated with endocrine dysfunction: a report of four cases and a review of the literature.
Am J Med, 107 (1999), pp. 169-176
[4.]
T. Murase, S. Nakamura, K. Kawauchi, H. Matsuzaki, C. Sakai, T. Inaba, et al.
An Asian variant of intravascular large Bcell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with hemophagocytic syndrome.
Br J Haematol, 111 (2000), pp. 826-834
[5.]
A. Tsukadaira, Y. Okubo, H. Ogasawara, K. Urushibata, T. Honda, I. Miura, et al.
Chromosomal aberrations in intravascular lymphomatosis.
Am J Clin Oncol, 25 (2002), pp. 178-181
[6.]
A.J.M. Ferreri, E. Campo, A. Ambrosetti, F. Ilariucci, J.F. Seymour, R. Willemze, et al.
Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma.
Ann Oncol, 15 (2004), pp. 1215-1221
Copyright © 2007. Academia Española de Dermatología y Venereología and Elsevier España, S.L.
